Pfizer Inc to split company into three units
U.S. drugmaker Pfizer Inc said on Wednesday it would split its business into three units and one of them would include a new hospital business segment. The three new units are innovative medicines, established medicines and consumer healthcare.
U.S. drugmaker Pfizer Inc said on Wednesday it would split its business into three units and one of them would include a new hospital business segment. The three new units are innovative medicines, established medicines and consumer healthcare. The company said the innovative medicines business and consumer healhcare would together comprise about three-quarter of its revenue based on 2017 results.
"This new structure represents a natural evolution of these businesses, given the ongoing strength of our in-market products and our late-stage pipeline and the expected significant reduction in the impact of patent protection losses post-2020," Pfizer`s Chief Executive Officer Ian Read said.
The move comes a day after the company decided to defer drug price increases for no more than six months, after U.S. President Donald Trump criticized Pfizer and other U.S. drugmakers for raising list prices of some medicines.
The established medicines unit would include the majority of the company`s off-patent brands, including Viagra and neurological disease treatment Lyrica.
Watch this Zee Business video here:
Pfizer said a loss of exclusivity for blockbuster fibromyalgia treatment Lyrica is expected to occur in or after December 2018.
The changes would come into effect at the start of fiscal 2019.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000
IRCTC Dividend 2024: Railway PSU announces 200% interim dividend - Check record date and other details
Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations
Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here
Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others
New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets
PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?
05:16 PM IST